Patent details

300918 Product Name: Naltrexon of een farmaceutisch aanvaardbaar zout daarvan, in het bijzonder naltrexonhydrochloride, en bupropion of een farmaceutisch aanvaardbaar zout daarvan, in het bijzonder bupropionhydrochloride

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300918
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2316456
Status:
SPC in force
Application number:
300918
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/14/988
Marketing Authorization Type:
EEA
Marketing Authorization Date:
30/03/2015
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
11/12/2017
First Marketing Authorization date:
30/03/2015
Grant date:
09/01/2018
Activation date:
21/04/2024
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
14/12/2017
SPC/SPC Extension Expiration Date:
20/04/2029
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
11/12/2017
 
 

 

Name:
Orexigen Therapeutics, Inc.
Address:
3344 North Torrey Pines Court, Suite 200, La Jolla, CA 92037, United States of America (US)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
28/07/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
11/12/2017
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
28/07/2025

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
17/24
Publication date:
24/04/2024
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
03/18
Publication date:
10/01/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
51/17
Publication date:
20/12/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/04/2026
Annual Fee Number:
23
Annual Fee Amount:
2000 Euro
Last Annual Payment Date:
08/04/2025
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
1800 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
10/01/2018 Outgoing Correspondence Outgoing Letter 1 PDF /7/6/9/3/2/0800223967/docs/300918_3_outgoingcorrespondence20180110025052043.pdf
10/01/2018 SPC Documents Certificate SPC 1 PDF /7/6/9/3/2/0800223967/docs/300918_4_supplprotectioncertificate20180110025052141.pdf
14/12/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /7/6/9/3/2/0800223967/docs/300918_0_181007l174.pdf
11/12/2017 SPC Documents Summary of the characteristics of the product 23 PDF /7/6/9/3/2/0800223967/docs/300918_1_supplprotectioncertificate20171214020420136.pdf
11/12/2017 SPC Documents Annex SPC 3 PDF /7/6/9/3/2/0800223967/docs/300918_2_supplprotectioncertificate20171214020420228.pdf
11/12/2017 SPC Documents Marketing Authorization SPC 3 PDF /7/6/9/3/2/0800223967/docs/300918_5_supplprotectioncertificate20171214020420043.pdf
11/12/2017 SPC Documents Annex SPC 14 PDF /7/6/9/3/2/0800223967/docs/300918_6_supplprotectioncertificate20171214020420315.pdf
11/12/2017 SPC Documents Accompanying letter SPC 2 PDF /7/6/9/3/2/0800223967/docs/300918_7_supplprotectioncertificate20210114014117335.pdf
11/12/2017 Application Form First filed application form 3 PDF /7/6/9/3/2/0800223967/docs/300918_8_applicationform20171214020419800.pdf